After nearly two decades of development, we have built a comprehensive product portfolio, comprising (i) staplers, including endoscopic staplers, smart staplers and open staplers, applicable to multiple surgical specialties, ranging from gastrointestinal, gynecologic and thoracic surgeries to sleeve gastrectomy surgeries for weight control, and (ii) other instruments and accessories for minimally invasive and open surgeries, such as ultrasonic scalpels and disposable fixation devices for hernia repair. We also market and distribute sutures, hernia meshes and blood vessel titanium clips manufactured by third parties as part of our integrated product offerings to our customers, and manufacture and sell certain products to OEM customers.

We had over 300 models of products on offer.  3 and 61 of our products had been certified as Class III and Class II medical devices in China, respectively, and our key products had received FDA approvals for 7 products, CE Marks for 21 products and MDSAP recognitions for 11 products. We have also developed a robust new product pipeline, including a laparoscopic surgical robot, which we expect to launch in 2024, if approved. As of the Latest Practicable Date, we had 19 product candidates, including 6 potential Class III medical devices and 13 potential Class II medical devices. As of the same date, we had two products that had received CE Marks and were in product registration process in China. With our comprehensive product portfolio, we aim to provide an “all-in-one” surgical toolkit that can make MIS safer, simpler, faster and more affordable.

Quality Control

Testing, control and tracking guarantees quality: every single stapler has to pass a firing test before being placed to the market. Moreover, every single stapler and cartridge is photographed and stored for tracking, to ensure that every single staple has been correctly positioned.

R&D Collaboration

Sales, marketing and R&D teams cooperate closely. We convert market insights into innovative products and solutions for clinical demands.

Team & Intellectual Property

Our R&D team has more than 40 professional engineers.

We hold over 470 IP rights in total, including 270+ granted patents, with over 100 patent applications under review.

Organization & Product Lines

Specialized groups focus on circular staplers, linear cutting staplers, hernia repair meshes, PPH devices, endoscopic clips, powered endoscopic staplers and ultrasonic scalpels.

Support teams cover IP management, product maintenance, packaging design and design control to support full-cycle R&D.

ISO 14001

In 2023, Panther received its ISO 14001 certification, an internationally recognized standard for environmental management systems (EMS).
Panther Healthcare is committed to combining its business growth with environmental responsibility for a sustainable future.